These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21982514)

  • 41. Inhibitory effects of ZSTK474, a novel phosphoinositide 3-kinase inhibitor, on osteoclasts and collagen-induced arthritis in mice.
    Toyama S; Tamura N; Haruta K; Karakida T; Mori S; Watanabe T; Yamori T; Takasaki Y
    Arthritis Res Ther; 2010; 12(3):R92. PubMed ID: 20482767
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Arginine-rich anti-vascular endothelial growth factor (anti-VEGF) hexapeptide inhibits collagen-induced arthritis and VEGF-stimulated productions of TNF-alpha and IL-6 by human monocytes.
    Yoo SA; Bae DG; Ryoo JW; Kim HR; Park GS; Cho CS; Chae CB; Kim WU
    J Immunol; 2005 May; 174(9):5846-55. PubMed ID: 15843589
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blockade of NKG2D ameliorates disease in mice with collagen-induced arthritis: a potential pathogenic role in chronic inflammatory arthritis.
    Andersson AK; Sumariwalla PF; McCann FE; Amjadi P; Chang C; McNamee K; Tornehave D; Haase C; Agersø H; Stennicke VW; Ahern D; Ursø B; Trowsdale J; Feldmann M; Brennan FM
    Arthritis Rheum; 2011 Sep; 63(9):2617-29. PubMed ID: 21618462
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The soluble tumor necrosis factor receptor etanercept: a new strategy for the treatment of autoimmune rheumatic disease.
    Cole P; Rabasseda X
    Drugs Today (Barc); 2004 Apr; 40(4):281-324. PubMed ID: 15190385
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell cycle regulation therapy combined with cytokine blockade enhances antiarthritic effects without increasing immune suppression.
    Hosoya T; Iwai H; Yamaguchi Y; Kawahata K; Miyasaka N; Kohsaka H
    Ann Rheum Dis; 2016 Jan; 75(1):253-9. PubMed ID: 25165034
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unmasking of a protective tumor necrosis factor receptor I-mediated signal in the collagen-induced arthritis model.
    Williams-Skipp C; Raman T; Valuck RJ; Watkins H; Palmer BE; Scheinman RI
    Arthritis Rheum; 2009 Feb; 60(2):408-18. PubMed ID: 19180511
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Novel Etanercept-loaded Nano-emulsion for Targeted Treatment of Inflammatory Arthritis
    Li C; Lu G; Jiang Y; Su H; Li C
    Curr Drug Deliv; 2024; 21(8):1106-1113. PubMed ID: 37565561
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of immune and inflammatory responses on experimental arthritis following intraarticular gene transfer of tumor necrosis factor receptor-immunoglobulin Fc.
    Zhou X; Gao K; Shen L; Zhao A; Wu X; Wang C; Wang J; Li B
    Rheumatol Int; 2012 Sep; 32(9):2605-14. PubMed ID: 21833532
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
    Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways.
    Liu C; He L; Wang J; Wang Q; Sun C; Li Y; Jia K; Wang J; Xu T; Ming R; Wang Q; Lin N
    J Ethnopharmacol; 2020 Oct; 260():113039. PubMed ID: 32497675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Construction of an anti-IL-1β scfv and TNFRI fusion protein and its therapeutic effect on RA mice model.
    Kan F; Ren G; Guo M; Qi J; Zhang Y; Han Y; Zhang Y; Li D
    Curr Pharm Biotechnol; 2014; 14(12):1048-61. PubMed ID: 24433504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TNF blockade in the treatment of rheumatoid arthritis: infliximab versus etanercept.
    Mikuls TR; Moreland LW
    Expert Opin Pharmacother; 2001 Jan; 2(1):75-84. PubMed ID: 11336570
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis.
    Murakami Y; Akahoshi T; Aoki N; Toyomoto M; Miyasaka N; Kohsaka H
    Arthritis Rheum; 2009 Jun; 60(6):1615-23. PubMed ID: 19479878
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TNF-α inhibitor reverse the effects of human umbilical cord-derived stem cells on experimental arthritis by increasing immunosuppression.
    Wu CC; Wu TC; Liu FL; Sytwu HK; Chang DM
    Cell Immunol; 2012; 273(1):30-40. PubMed ID: 22196378
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Involvement of peripheral and spinal tumor necrosis factor α in spinal cord hyperexcitability during knee joint inflammation in rats.
    König C; Zharsky M; Möller C; Schaible HG; Ebersberger A
    Arthritis Rheumatol; 2014 Mar; 66(3):599-609. PubMed ID: 24574220
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery and preclinical evaluation of KYS202004A, a novel bispecific fusion protein targeting TNF-α and IL-17A, in autoimmune disease models.
    Liu Z; Song L; Yang J; Liu H; Zhang Y; Pi X; Yan Y; Chen H; Yu D; Yin C; Liu T; Li X; Zhang C; Li D; Wang Z; Xiao W
    Int Immunopharmacol; 2024 Jul; 136():112383. PubMed ID: 38843642
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of drug and cell-based delivery: engineered adult mesenchymal stem cells expressing soluble tumor necrosis factor receptor II prevent arthritis in mouse and rat animal models.
    Liu LN; Wang G; Hendricks K; Lee K; Bohnlein E; Junker U; Mosca JD
    Stem Cells Transl Med; 2013 May; 2(5):362-75. PubMed ID: 23592838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of etanercept in chronic immune-mediated disease.
    Murdaca G; Spanò F; Contatore M; Guastalla A; Magnani O; Puppo F
    Expert Opin Drug Saf; 2014 May; 13(5):649-61. PubMed ID: 24654562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A potent and selective p38 inhibitor protects against bone damage in murine collagen-induced arthritis: a comparison with neutralization of mouse TNFalpha.
    Mihara K; Almansa C; Smeets RL; Loomans EE; Dulos J; Vink PM; Rooseboom M; Kreutzer H; Cavalcanti F; Boots AM; Nelissen RL
    Br J Pharmacol; 2008 May; 154(1):153-64. PubMed ID: 18297096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.